Ceritinib in Mutation and Oncogene Directed Therapy in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Ceritinib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 10 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 09 Jun 2015 Planned initiation date changed from 1 Jun 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov.
- 29 May 2015 Trial design presented at 51st Annual Meeting of the American Society of Clinical Oncology.